Flood transfusions and risk of non-Hodgkin's lymphoma subtypes and chronic lymphocytic leukemia

被引:0
|
作者
Cerhan, JR
Wallace, RB
Dick, F
Kemp, J
Parker, AS
Zheng, W
Sellers, TA
Folsom, AR
机构
[1] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA
[2] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Med, Dept Pathol, Iowa City, IA 52242 USA
[4] Univ S Carolina, Sch Publ Hlth, S Carolina Canc Ctr, Columbia, SC 29203 USA
[5] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55454 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allogeneic blood transfusion has been suggested as a risk factor for non-Hodgkin's lymphoma (NHL), possibly specific to certain NHL subtypes, or chronic lymphocytic leukemia (CLL). Self-reported transfusion history and risk of NHL subtypes and CLL were examined in a cohort of 37,934 older Iowa women, using data from a questionnaire mailed in 1986. Through 1997, 229 cases of NHL and 57 cases of CLL in the cohort were identified through linkage to the Iowa Surveillance, Epidemiology and End Results Cancer Registry. Women who reported ever receiving a blood transfusion were at increased risk for all NHLs [age adjusted relative risk (RR), 1.6; 95% confidence interval (CI), 1.2-2.1). On the basis of the Working Formulation classification, blood transfusion was positively associated with low-grade NHL (RR, 2.7; 95% CI, 1.7-4.5) but not with intermediate-grade NHL (RR, 1.1; 95% CI, 0.7-1.6); there were only 8 cases of high-grade NHL. Blood transfusion was positively associated with follicular (RR, 2.8; 95% CI, 1.6-5.1) and small lymphocytic (RR, 3.4; 95% CI, 1.5-7.9) NHL subtypes but not with diffuse NHL (RR, 1.0; 95% CI, 0.7-1.5). There was also a positive association with CLL (RR, 1.7; 95% CI, 1.0-3.0). Finally, transfusion was associated with nodal (RR, 1.8; 95% CI, 1.3-2.5) but not extranodal (RR, 1.2; 95% CI, 0.7-2.1) NHL. Further adjustment for marital status, farm residence, diabetes, alcohol use, smoking, and red meat and fruit consumption did not alter these associations. In conclusion, prior blood transfusion was associated with NHL and CLL, and the strongest associations were seen for low-grade NHL, particularly follicular and small lymphocytic NHL.
引用
收藏
页码:361 / 368
页数:8
相关论文
共 50 条
  • [31] Clinical experience of bendamustine treatment for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Spain
    Sanchez-Gonzalez, Blanca
    Javier Penalver, F.
    Medina, Angeles
    Guillen, Helga
    Calleja, Marta
    Gironella, Mercedes
    Arranz, Reyes
    Sebastian, Elena
    de Ona, Raquel
    Canovas, Araceli
    de la Fuente, Ignacio
    Grande, Carlos
    Manuel Sancho, Juan
    Perez, Ricardo
    Domingo, Eva
    Luis Lopez-Lorenzo, Jose
    Prieto, Elena
    Panizo, Carlos
    Gorosquieta, Ana
    Perez, Inmaculada
    Manuel Cervera, Jose
    Marin, Miguel
    Mencha, Carmen
    Ramila, Elena
    Salar, Antonio
    LEUKEMIA RESEARCH, 2012, 36 (06) : 709 - 714
  • [32] Physical activity and the risk of non-Hodgkin lymphoma subtypes
    Boyle, Terry
    Spinelli, John J.
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 123 - 123
  • [33] Large cell non-Hodgkin's lymphoma and Hodgkin's disease arising synchronously in a patient with chronic lymphocytic leukemia: Importance of immunocytochemistry
    Gopal, AK
    Schuetze, SH
    Maloney, DG
    Weiden, PL
    BLOOD, 1999, 94 (07) : 2537 - 2537
  • [34] Barriers to the Access and Use of Rituximab in Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia: A Physician Survey
    Baer, William H., II
    Maini, Archana
    Jacobs, Ira
    PHARMACEUTICALS, 2014, 7 (05): : 530 - 544
  • [35] Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma
    Hendry, L
    Bowen, A
    Matutes, E
    Swansbury, J
    Catovsky, D
    LEUKEMIA & LYMPHOMA, 2004, 45 (05) : 945 - 950
  • [36] QUALITY OF LIFE IN CHRONIC LYMPHOCYTIC LEUKEMIA AND NON-HODGKIN'S LYMPHOMA: AN ONCOLOGY CENTER STUDY OF 80 PATIENTS
    Mihaescu, G.
    Stoian, A.
    Buzas, R.
    Negru, A.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 768 - 769
  • [37] Phase I study of bryostatin 1 in patients with relapsed non-Hodgkin's lymphoma and chronic lymphocytic leukemia
    Varterasian, ML
    Mohammad, RM
    Eilender, DS
    Hulburd, K
    Rodriguez, DH
    Pemberton, PA
    Pluda, JM
    Dan, MD
    Pettit, GR
    Chen, BDM
    Al-Katib, AM
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (01) : 56 - 62
  • [38] CLINICAL EXPERIENCE OF BENDAMUSTINE TREATMENT FOR NON-HODGKIN LYMPHOMA AND CHRONIC LYMPHOCYTIC LEUKEMIA: SPANISH REGISTRY
    Sanchez-Gonzalez, B.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 374 - 374
  • [39] Increased Metastasis of Malignant Fibrous Histiocytoma in Patients With Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma
    Kubica, Agnieszka W.
    Rose, Peter S.
    Weaver, Amy L.
    Brewer, Jerry D.
    MAYO CLINIC PROCEEDINGS, 2011, 86 (08) : 738 - 743
  • [40] Fcγ Receptor Polymorphisms and Clinical Efficacy of Rituximab in Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia
    Zhuang, Yun
    Xu, Wei
    Shen, Yunfeng
    Li, Jianyong
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2010, 10 (05): : 347 - 352